As shown in Fig 6C, Sunitinib treatment of mECK36 tumors showed a stronger anti-tumor effect than Imatinib, leading to a complete inhibition of tumor growth, which occurred with complete blockage of PDGFRA phosphorylation (Fig 6D). The gene discussed is PDGFRA; the disease is neoplasm.